Panel Discussion

Sunday, March 9, 2025

1:05 PM – 1:25 PM ET

Panel Moderator(s)

Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

Disclosure(s): Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panel Discussant(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)
Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): No financial relationships to disclose
Antonio Colombo, MD

Professor of Cardiology
Humanitas IRCCS
Milan, Lombardia, Italy

Disclosure(s): No financial relationships to disclose
Philippe Généreux, MD

Director, Valve & Structural Heart Center
Morristown Medical Center
Morristown, New Jersey, United States

Disclosure(s): 4C Medical Technologies, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
James K. Min, MD

Professor of Radiology and Medicine, Director
Dalio Institute of Cardiovascular Imaging
Weill Cornell Medical College
New York, NY, United States

Disclosure information not submitted.
Stanton J. Rowe, PhD

CEO
NXT Biomedical
Irvine, California, United States

Disclosure(s): Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)
Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Officer
Abiomed a Johnson + Johnson MedTech Company
Charlotte, North Carolina, United States

Disclosure(s): Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)

Disclosure(s):

Nabil Dib, MD, MSc, FACC: Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Spencer B. King, MD, MACC, MSCAI, III: No financial relationships to disclose

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

William T. Abraham, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

Daniel Burkhoff, MD, PhD: No financial relationships to disclose

Antonio Colombo, MD: No financial relationships to disclose

Philippe Généreux, MD: 4C Medical Technologies, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Stanton J. Rowe, PhD: Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Charles A. Simonton, MD, FACC, FSCAI: Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)